Tenascin-C signaling through induction of 14-3-3 tau
暂无分享,去创建一个
[1] H. Betz,et al. Identification of cofilin and LIM-domain-containing protein kinase 1 as novel interaction partners of 14-3-3 zeta. , 2003, The Biochemical journal.
[2] G. Bokoch,et al. 14-3-3 Regulates Actin Dynamics by Stabilizing Phosphorylated Cofilin , 2002, Current Biology.
[3] Takashi Tsuruo,et al. Akt-dependent Phosphorylation of p27Kip1Promotes Binding to 14-3-3 and Cytoplasmic Localization* , 2002, The Journal of Biological Chemistry.
[4] S. Bell,et al. Changes in tenascin-C isoform expression in invasive and preinvasive breast disease. , 2002, Cancer research.
[5] Margareta M. Mueller,et al. Clinical impact and functional aspects of tenascin‐C expression during glioma progression , 2002, International journal of cancer.
[6] J. Avruch,et al. 14-3-3 Proteins: Active Cofactors in Cellular Regulation by Serine/Threonine Phosphorylation* , 2002, The Journal of Biological Chemistry.
[7] J. Moyano,et al. Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. , 2001, Cancer research.
[8] S. Masters,et al. 14-3-3 Proteins Mediate an Essential Anti-apoptotic Signal* , 2001, The Journal of Biological Chemistry.
[9] P. Heikkilä,et al. Increased Expression of Tenascin in Pheochromocytomas Correlates With Malignancy , 2001, The American journal of surgical pathology.
[10] M. V. van Hemert,et al. 14‐3‐3 proteins: key regulators of cell division, signalling and apoptosis , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.
[11] Y. Nakajima,et al. Annexin II overexpression correlates with stromal tenascin‐C overexpression , 2001, Cancer.
[12] J. Bos,et al. Rap1 signalling: adhering to new models , 2001, Nature Reviews Molecular Cell Biology.
[13] J. Guan,et al. Identification of a novel interaction between integrin β1 and 14-3-3β , 2001, Oncogene.
[14] D. C. Han,et al. Identification of a novel interaction between integrin beta1 and 14-3-3beta. , 2001, Oncogene.
[15] H. Koelbl,et al. Tenascin-A marker for the malignant potential of preinvasive breast cancers. , 2000, Gynecologic oncology.
[16] P. Jones,et al. Tenascin-C in development and disease: gene regulation and cell function. , 2000, Matrix biology : journal of the International Society for Matrix Biology.
[17] R. Chiquet‐Ehrismann,et al. Adhesion modulation by antiadhesive molecules of the extracellular matrix. , 2000, Experimental cell research.
[18] Y. Takihara,et al. Role of the β isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation , 2000 .
[19] G. Berruti. A novel rap1/B-Raf/14-3-3 theta protein complex is formed in vivo during the morphogenetic differentiation of postmeiotic male germ cells. , 2000, Experimental cell research.
[20] W. V. van Blitterswijk,et al. Protein kinase C activation by acidic proteins including 14-3-3. , 2000, The Biochemical journal.
[21] Anthony J. Muslin,et al. 14‐3‐3 proteins block apoptosis and differentially regulate MAPK cascades , 2000, The EMBO journal.
[22] S. Masters,et al. 14-3-3 proteins: structure, function, and regulation. , 2000, Annual review of pharmacology and toxicology.
[23] A. Kumagai,et al. Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25. , 1999, Genes & development.
[24] T. Schulthess,et al. Concerted action of tenascin-C domains in cell adhesion, anti-adhesion and promotion of neurite outgrowth. , 1997, Journal of cell science.
[25] G. Vollmer. Biologic and oncologic implications of tenascin-C/hexabrachion proteins. , 1997, Critical reviews in oncology/hematology.
[26] Elizabeth Yang,et al. Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.
[27] K. Crossin,et al. Tenascin: A multifunctional extracellular matrix protein with a restricted distribution in development and disease , 1996, Journal of cellular biochemistry.
[28] T. Mustelin,et al. Inhibition of phosphatidylinositol 3-kinase activity by association with 14-3-3 proteins in T cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[29] W. Kolch,et al. Regulation of Raf‐1 kinase activity by the 14‐3‐3 family of proteins. , 1995, The EMBO journal.
[30] W. Fantl,et al. Activation of Raf-1 by 14-3-3 proteins , 1994, Nature.
[31] K. Xia,et al. Interaction of the protein kinase Raf-1 with 14-3-3 proteins. , 1994, Science.
[32] R. Chiquet‐Ehrismann. Tenascin and other adhesion-modulating proteins in cancer. , 1993, Seminars in cancer biology.
[33] R. Chiquet‐Ehrismann,et al. Participation of tenascin and transforming growth factor-beta in reciprocal epithelial-mesenchymal interactions of MCF7 cells and fibroblasts. , 1989, Cancer research.
[34] R. Chiquet‐Ehrismann,et al. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis , 1986, Cell.